ITLN1 and neoplasm: Mechanistically, these findings point to omentin as a modulator of pathways central to tumor progression, including PI3K/NF-κB, HNF4α/β-catenin, and Sirt1–p53–JNK signaling, as well as its regulation via TMEM207-mediated stabilization.